Alternative promoters

Show results for

Unknown (1098)
Genomics (478)
Transcriptomics (288)
Other (41)
Methylation profiling (10)
Proteomics (10)
Metabolomics (1)

Organisms

Homo sapiens (163)
Mus musculus (140)
Drosophila melanogaster (23)
Saccharomyces cerevisiae (22)
Escherichia coli str. K-12 substr. MG1655 (10)
Danio rerio (9)
Arabidopsis thaliana (7)
Sinorhizobium meliloti (4)
Rattus norvegicus (4)
Candida albicans (4)
Bacillus subtilis subsp. subtilis str. 168 (3)
Pongo pygmaeus (2)
Saccharomyces paradoxus (2)
Saccharomyces mikatae (2)
Gossypium hirsutum (2)
Yersinia pestis (2)
Staphylococcus aureus (2)
Solanum lycopersicum (2)
Lachancea waltii (1)
Dickeya dadantii 3937 (1)
Dictyostelium discoideum (1)
Debaryomyces hansenii (1)
Kluyveromyces lactis (1)
Oryzias latipes (1)
Yarrowia lipolytica (1)
Medicago truncatula (1)
Listeria monocytogenes (1)
Campylobacter jejuni (1)
Bacillus subtilis (1)
Bos taurus (1)

Organisms

Homo sapiens (104)
Mus musculus (100)
Saccharomyces cerevisiae (16)
Drosophila melanogaster (15)
Anopheles gambiae (12)
Danio rerio (7)
Caenorhabditis elegans (5)
Arabidopsis thaliana (4)
Flavobacterium psychrophilum (3)
Escherichia coli str. K-12 substr. MG1655 (3)
Saccharolobus solfataricus P2 (2)
Mycoplasmoides pneumoniae M129 (2)
Saccharolobus islandicus REY15A (2)
Chlamydia trachomatis (2)
Lactiplantibacillus plantarum (2)
Sus scrofa (2)
Plasmodium falciparum (2)
Saccharolobus islandicus LAL14/1 (1)
Saccharomyces cerevisiae W303 (1)
Chrysemys picta bellii (1)
Pongo pygmaeus (1)
Oikopleura dioica (1)
Bacillus subtilis subsp. subtilis NCIB 3610 = ATCC 6051 = DSM 10 (1)
Escherichia coli str. K-12 substr. W3110 (1)
Geobacter sulfurreducens (1)
Yersinia pestis (1)
Sus scrofa scrofa (1)
Synechocystis sp. PCC 6803 (1)
Escherichia coli K-12 (1)
Clostridioides difficile (1)

Repository

ENA (357)
geo (294)
biostudies-arrayexpress (161)
pride (9)
EGA (5)
MetaboLights (1)
PanoramaPublic (1)

Tissue

Cell culture (3)
Epithelial cell (2)
Colon (1)
Early embryonic cell (1)
Embryonic fibroblast (1)
Embryonic stem cell (1)
Endothelial cell of umbilical vein (1)
Stomach (1)
Umbilical vein endothelial cell (1)

Disease

Colon cancer (1)
Stomach cancer (1)

Technology Type

Mass Spectrometry (9)
Gel-based experiment (3)
Shotgun proteomics (3)
Affinity purification coupled with mass spectrometry proteomics (2)
Bottom-up proteomics (2)
Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
SWATH MS (1)

Instrument Platform

Illumina HiSeq 2500 (6)
Illumina NovaSeq 6000 (2)
Illumina HiSeq 2000 (2)
NextSeq 500 (2)
Agilent Microarray Scanner (mod. G2505C) (1)
AB SOLiD 4 System (1)
Bioanalyser (1)
DNA Microarray Scanner BA [Agilent Technologies] (1)
Variable Atmosphere Incubator (1)
Ion Torrent PGM (1)
Illumina HiSeq 1000 (1)
MinION (1)
Illumina HiSeq 3000 (1)
Illumina HiSeq 4000 (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2023 (54)
2010 (47)
2021 (41)
2012 (35)
2022 (31)
2014 (30)
2025 (28)
2020 (25)
2015 (22)
2013 (21)
2011 (21)
2026 (21)
2016 (18)
2024 (16)
2019 (15)
2009 (11)
2008 (9)
2018 (8)
2017 (7)
2007 (3)
2006 (2)

Metabolite Name

Cer 18:1;2O/15:0 (1)
HexCer 22:3;2O/17:1;O (1)
PG 4:0_15:0 (1)
SL 17:0;O/16:0;O (1)
MGDG 15:0_16:0 (1)
PG O-24:6_20:5 (1)
PC 16:1_20:5 (1)
Cer 16:0;2O/16:0;(2OH) (1)
PC 13:0_15:0 (1)
PG O-19:2_15:0 (1)
PE 13:0_15:0 (1)
PC O-20:5_3:0 (1)
Cer 15:2;3O/22:1;(2OH) (1)
PC O-16:1_20:4 (1)
LPG O-18:5 (1)
Cer 15:0;2O/14:0 (1)
PG 16:0_21:2 (1)
ST 24:1;O4/18:2 (1)
MGDG O-28:1_20:5 (1)
HexCer 24:0;2O/9:0 (1)
2-(1H-benzimidazol-2-yl)-3-phenylacrylonitrile (1)
PG 16:0_22:6;O (1)
MGDG O-28:1_18:2 (1)
MGDG O-22:4_20:5 (1)
NAGly 15:0/15:0 (1)
LNAPE 17:0/N-2:0 (1)
MGDG O-26:3_20:4 (1)
LPG O-20:3 (1)
SL 18:0;O/16:1;O (1)
PG O-15:1_18:1 (1)

First Public Date

2023 (60)
2014 (39)
2021 (33)
2025 (32)
2022 (32)
2024 (30)
2020 (29)
2026 (26)
2013 (19)
2019 (13)
2015 (13)
2018 (10)
2017 (10)
2016 (10)
2012 (1)

Classification

bacteria (12)
protozoa (2)
fungi (1)

Study type

Transcription profiling by array (64)
RNA-seq of coding RNA (27)
ChIP-seq (25)
ChIP-chip by tiling array (9)
Transcription profiling by tiling array (7)
Methylation profiling by array (5)
Other (4)
RNA-seq of total RNA (4)
ChIP-chip by array (2)
RNA-seq of coding RNA from single cells (2)
Methylation profiling by high throughput sequencing (2)
RNA-seq of non coding RNA (2)
Cell line - Single-cell sequencing (1)
Unknown experiment type (1)
Human - Single-cell sequencing (1)
Cell line - One-color microarray (1)
Animal - High-throughput sequencing (1)
Cell line - High-throughput sequencing (1)
RNAi profiling by array (1)
ATAC-seq (1)

Release Date

2014 (84)
2021 (83)
2023 (80)
2022 (76)
2025 (76)
2016 (73)
2024 (73)
2010 (71)
2018 (67)
2012 (67)
2019 (66)
2020 (64)
2017 (60)
2013 (51)
2015 (49)
2009 (45)
2011 (36)
2007 (26)
2008 (24)
2006 (15)
2005 (14)
2026 (12)
2004 (11)
2002 (8)
2003 (7)
2000 (6)
1999 (6)
2001 (4)
1998 (2)
1997 (2)

Lab affiliation

Ackermannweg 4, 55128 Mainz, Germany (1)
Cancer Science Institute of Singapore, National University of Singapore (1)
Department of Anatomy and Cell Biology, Université de Sherbrooke, Canada (1)
Group Leader, Department of Molecular Microbiology (1)
Head of System Biology Lab. at Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (1)
Lund Stem Cell Center, Division of Molecular Hematology, Lund University, Lund, Sweden (1)
Molecular Biology and Genetics, Cornell University, USA (1)
Raymond H. Wittcoff Distinguished Professor and Head Department of Biochemistry and Molecular Biophysics Washington University School of Medicine St. Louis, MO 63110 (1)
University Hospital Wuerzburg, Department of Dermatology, Venereology and Allergology (1)

Previous page
1 / 193
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 193
Next page

Sort by:

Relevance

Page size

Brd2 regulates gene expression and alternative splicing.

We analyzed a role of Brd2 protein in transcription and alternative splicing. 289 genes change alternative splicing after Brd2 knockdown and 1459 genes alter gene expression compared to cells treated with negative control siRNA. 6 samples (3 independent samples of cells treated with Brd2 siRNA, 3 sa...

ORGANISM(S): Homo sapiens

2013-12-03 | E-GEOD-39937 | biostudies-arrayexpress

Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development

Mammalian development is an intricate process regulated by multiple gene isoforms and their epigenetic states, which are yet undefined. Using integrative massive parallel sequencing and bioinformatics approach, we built genome-wide inventory of transcript variants, their promoters and histone modifi...

ORGANISM(S): Mus musculus

2011-06-07 | E-GEOD-23525 | biostudies-arrayexpress

Intragenic enhancers act as alternative promoters

This SuperSeries is composed of the following subset Series: GSE26877: Nprl3 is Required for Normal Development of the Cardiovascular System GSE27918: Genome-wide maps of chromatin state in mouse erythroid cells. GSE27919: Genome-wide map of DNaseI hypersensitivity in mouse erythroid cells. GSE27920...

ORGANISM(S): Mus musculus

2012-01-30 | E-GEOD-27921 | biostudies-arrayexpress

Systematic Transcriptome Analysis Reveals the Crucial Role of Alternative Promoters in Hematopoietic Lineages

PRJNA1260541 | ENA

Enhancer-driven alternative promoters of imprinted genes.

Not available

S-EPMC6267961 | biostudies-literature

Chromatin-dependent cryptic promoters encode alternative protein isoforms in yeast

PRJNA488219 | ENA

Alternative promoters of Peg3 with maternal specificity.

Not available

S-EPMC4830991 | biostudies-literature

Recurrent epimutations activate gene body promoters in primary glioblastoma

Aberrant DNA hypomethylation may play an important role in the growth rate of glioblastoma (GBM), but the functional impact on transcription remains poorly understood. We assayed the GBM methylome with MeDIP-seq and MRE-seq, adjusting for copy number differences, in a small set of non-glioma CpG isl...

EGAS00001000685 | EGA

Selective Activation of Alternative MYC Core Promoters by Wnt-Responsive Enhancers.

Not available

S-EPMC6027352 | biostudies-literature

Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma.

Not available

S-EPMC8478642 | biostudies-literature